Diagnosis and classification of autoimmune gastritis

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 459-462

  Toh, Ban Hock ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b Healthscope Pathology   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; INTRINSIC FACTOR; PARIETAL CELL ANTIBODY; PEPSINOGEN;

ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE GASTRITIS; AUTOIMMUNE THYROIDITIS; CHRONIC GASTRITIS; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; ENDOCRINE DISEASE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRON DEFICIENCY; REVIEW; STOMACH ADENOCARCINOMA; STOMACH ATROPHY; STOMACH CARCINOID; STOMACH PARIETAL CELL;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PREVALENCE;

EID: 84896317988     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.048     Document Type: Review

References (56)

1. Toh B.H., Chan J., Kyaw T., Alderuccio F. Cutting edge issues in autoimmune gastritis. Clin Rev Allergy Immunol 2012, 42:269-278.
2. Neumann W.L., Coss E., Rugge M., Genta R.M. Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 2013.
3. Strickland R.G., Mackay I.R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973, 18:426-440.
4. Irvine W.J., Cullen D.R., Mawhinney H. Natural history of autoimmune achlorhydric atrophic gastritis. A 1-15-year follow-up study. Lancet 1974, 2:482-485.
5. Toh B.H., van Driel I.R., Gleeson P.A. Pernicious anemia. N Engl J Med 1997, 337:1441-1448.
6. Hershko C., Ronson A., Souroujon M., Maschler I., Heyd J., Patz J. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood 2006, 107:1673-1679.
7. Zhang Y., Weck M.N., Schottker B., Rothenbacher D., Brenner H. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev 2013, 22:821-826.
8. Cabrera de Leon A., Almeida Gonzalez D., Almeida A.A., Gonzalez Hernandez A., Carretero Perez M., Rodriguez Perez Mdel C., et al. Factors associated with parietal cell autoantibodies in the general population. Immunol Lett 2012, 147:63-66.
9. Lombardo L., Leto R., Molinaro G., Migliardi M., Ravarino N., Rocca R., et al. Prevalence of atrophic gastritis in dyspeptic patients in piedmont. A survey using the gastropanel test. Clin Chem Lab Med 2010, 48:1327-1332.
10. Telaranta-Keerie A., Kara R., Paloheimo L., Harkonen M., Sipponen P. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4256 volunteers without specific complaints. Scand J Gastroenterol 2010, 45:1036-1041.
11. Amedei A., Bergman M.P., Appelmelk B.J., Azzurri A., Benagiano M., Tamburini C., et al. Molecular mimicry between Helicobacter pylori antigens and h+, k+ - adenosine triphosphatase in human gastric autoimmunity. J Exp Med 2003, 198:1147-1156.
12. Veijola L.I., Oksanen A.M., Sipponen P.I., Rautelin H.I. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol 2010, 16:83-88.
13. Gao L., Weck M.N., Nieters A., Brenner H. Inverse association between a pro-inflammatory genetic profile and Helicobacter pylori seropositivity among patients with chronic atrophic gastritis: enhanced elimination of the infection during disease progression?. Eur J Cancer 2009, 45:2860-2866.
14. Saito M., Morioka M., Wakasa K., Izumiyama K., Mori A., Irie T., et al. In Japanese patients with type a gastritis with pernicious anemia the condition is very poorly associated with Helicobacter pylori infection. J Infect Chemother 2013, 19:208-210.
15. Fisher J.M., Rees C., Taylor K.B. Intrinsic-factor antibodies in gastric juice of pernicious-anemia patients. Lancet 1966, 2:88-89.
16. Stabler S.P. Clinical practice. Vitamin b12 deficiency. N Engl J Med 2013, 368:149-160.
17. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996, 156:1097-1100.
18. Hershko C., Patz J., Ronson A. The anemia of achylia gastrica revisited. Blood Cells Mol Dis 2007, 39:178-183.
19. Watson E.M. The association of diabetes mellitus and pernicious anaemia. Can Med Assoc J 1933, 29:11-17.
20. McGregor H.G. Pernicious anaemia with diabetes mellitus. Br Med J 1937, 2:617-619.
21. Whittingham S., Youngchaiyud U., Mackay I.R., Buckley J.D., Morris P.J. Thyrogastric autoimmune disease. Studies on the cell-mediated immune system and histocompatibility antigens. Clin Exp Immunol 1975, 19:289-299.
22. Zauli D., Tosti A., Biasco G., Miserocchi F., Patrizi A., Azzaroni D., et al. Prevalence of autoimmune atrophic gastritis in vitiligo. Digestion 1986, 34:169-172.
23. Massironi S., Cavalcoli F., Rossi R.E., Conte D., Spampatti M.P., Ciafardini C., et al. Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: a transversal prospective study. Eur J Endocrinol 2013, 168:755-761.
24. De Block C.E., De Leeuw I.H., Van Gaal L.F. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab 2008, 93:363-371.
25. Kakleas K., Kostaki M., Critselis E., Karayianni C., Giannaki M., Anyfantakis K., et al. Gastric autoimmunity in children and adolescents with type 1 diabetes: a prospective study. Horm Res Paediatr 2012, 77:121-126.
26. Lam-Tse W.K., Batstra M.R., Koeleman B.P., Roep B.O., Bruining M.G., Aanstoot H.J., et al. The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes. Pediatr Endocrinol Rev 2003, 1:22-37.
27. Tsirogianni A., Pipi E., Soufleros K. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus. Autoimmun Rev 2009, 8:687-691.
28. Lahner E., Centanni M., Agnello G., Gargano L., Vannella L., Iannoni C., et al. Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med 2008, 121:136-141.
29. Ness-Abramof R., Nabriski D.A., Braverman L.E., Shilo L., Weiss E., Reshef T., et al. Prevalence and evaluation of b12 deficiency in patients with autoimmune thyroid disease. Am J Med Sci 2006, 332:119-122.
30. Burman P., Kampe O., Kraaz W., Loof L., Smolka A., Karlsson A., et al. A study of autoimmune gastritis in the postpartum period and at a 5-year follow-up. Gastroenterology 1992, 103:934-942.
31. Vanoli A., La Rosa S., Luinetti O., Klersy C., Manca R., Alvisi C., et al. Histologic changes in type a chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions. Hum Pathol 2013.
32. Nikou G.C., Angelopoulos T.P. Current concepts on gastric carcinoid tumors. Gastroenterol Res Pract 2012, 2012:287825.
33. Kokkola A., Sjoblom S.M., Haapiainen R., Sipponen P., Puolakkainen P., Jarvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol 1998, 33:88-92.
34. Elsborg L., Mosbech J. Pernicious anaemia as a risk factor in gastric cancer. Acta Med Scand 1979, 206:315-318.
35. Vannella L., Lahner E., Osborn J., Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 2013, 37:375-382.
36. Uibo R., Krohn K., Villako K., Tammur R., Tamm A. The relationship of parietal cell, gastrin cell, and thyroid autoantibodies to the state of the gastric mucosa in a population sample. Scand J Gastroenterol 1984, 19:1075-1080.
37. Uibo R., Krohn K., Villako K., Tammur R., Tamm A. Relation of parietal cell and thyroid antibodies to the state of gastric mucosa and basal serum gastrin levels during a 6-year follow up. Clin Exp Immunol 1989, 77:202-205.
38. Toh B.H., Alderuccio F. Pernicious anaemia. Autoimmunity 2004, 37:357-361.
39. Chuang J.S., Callaghan J.M., Gleeson P.A., Toh B.H. Diagnostic elisa for parietal cell autoantibody using tomato lectin-purified gastric h+/k(+)-atpase (proton pump). Autoimmunity 1992, 12:1-7.
40. Sugiu K., Kamada T., Ito M., Kaya S., Tanaka A., Kusunoki H., et al. Evaluation of an elisa for detection of anti-parietal cell antibody. Hepatogastroenterology 2006, 53:11-14.
41. Toh B.H., Kyaw T., Taylor R., Pollock W., Schlumberger W. Parietal cell antibody identified by elisa is superior to immunofluorescence, rises with age and is associated with intrinsic factor antibody. Autoimmunity 2012, 45:527-532.
42. Lahner E., Norman G.L., Severi C., Encabo S., Shums Z., Vannella L., et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol 2009, 104:2071-2079.
43. Khan S., Del-Duca C., Fenton E., Holding S., Hirst J., Dore P.C., et al. Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia. J Clin Pathol 2009, 62:439-441.
44. Tozzoli R., Kodermaz G., Perosa A.R., Tampoia M., Zucano A., Antico A., et al. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev 2010, 10:80-83.
45. Carmel R. Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: influence of patient age and race. Clin Exp Immunol 1992, 89:74-77.
46. Alonso N., Granada M.L., Soldevila B., Salinas I., Joaquin C., Reverter J.L., et al. Serum autoimmune gastritis markers, pepsinogen i and parietal cell antibodies, in patients with type 1 diabetes mellitus: a 5-year prospective study. J Endocrinol Invest 2011, 34:340-344.
47. Korstanje A., den Hartog G., Biemond I., Lamers C.B. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol Suppl 2002, 22-26.
48. Antico A., Tampoia M., Villalta D., Tonutti E., Tozzoli R., Bizzaro N. Clinical usefulness of the serological gastric biopsy for the diagnosis of chronic autoimmune gastritis. Clin Dev Immunol 2012, 2012:520970.
49. Agreus L., Kuipers E.J., Kupcinskas L., Malfertheiner P., Di Mario F., Leja M., et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012, 47:136-147.
50. Korstanje A., van Eeden S., Offerhaus J.A., Waltman F.L., Hartog G., Roelandse F.W., et al. Comparison between serology and histology in the diagnosis of advanced gastric body atrophy: a study in a Dutch primary community. J Clin Gastroenterol 2008, 42:18-22.
51. Nasrollahzadeh D., Aghcheli K., Sotoudeh M., Shakeri R., Persson E.C., Islami F., et al. Accuracy and cut-off values of pepsinogens i, ii and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One 2011, 6:e26957.
52. Checchi S., Montanaro A., Pasqui L., Ciuoli C., Cevenini G., Sestini F., et al. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab 2007, 92:4346-4351.
53. Suzuki H., Masaoka T., Hosoda H., Nomura S., Ohara T., Kangawa K., et al. Plasma ghrelin concentration correlates with the levels of serum pepsinogen i and pepsinogen i/ii ratio - a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology 2004, 51:1249-1254.
54. Kawashima J., Ohno S., Sakurada T., Takabayashi H., Kudo M., Ro S., et al. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol 2009, 44:1046-1054.
55. Bresky G., Mata A., Llach J., Ginis M.A., Pellisi M., Soria M.T., et al. Endoscopic findings in a biennial follow-up program in patients with pernicious anemia. Hepatogastroenterology 2003, 50:2264-2266.
56. Zullo A., Hassan C., Repici A., Annibale B. Intestinal metaplasia surveillance: searching for the road-map. World J Gastroenterol 2013, 19:1523-1526.